Delayed lactose utilization among Shiga toxin-producing Escherichia coli of serogroup O121.


Journal

Food microbiology
ISSN: 1095-9998
Titre abrégé: Food Microbiol
Pays: England
ID NLM: 8601127

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 04 06 2021
revised: 31 08 2021
accepted: 09 09 2021
entrez: 23 11 2021
pubmed: 24 11 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Two outbreaks of Shiga toxin-producing Escherichia coli O121:H19 associated with wheat flour, in the United States of America and Canada, involved strains with an unusual phenotype, delayed lactose utilization (DLU). These strains do not ferment lactose when initially cultured on MacConkey agar (MAC), but lactose fermentation occurs following subculture to a second plate of MAC. The prevalence of DLU was determined by examining the β-galactosidase activity of 49 strains of E. coli O121, and of 37 other strains of E. coli. Twenty four of forty three O121:H19 and one O121:NM displayed DLU. Two strains (O121:NM and O145:H34) did not have detectable β-galactosidase activity. β-glucuronidase activity of O121 strains was also determined. All but six DLU strains had normal β-glucuronidase activity. β-glucuronidase activity was suppressed on MAC for 17 of 23 O121 non-DLU strains. Genomic analysis found that DLU strains possessed an insertion sequence, IS600 (1267 bp), between lacZ (β-galactosidase) and lacY (β-galactoside permease), that was not present in strains exhibiting normal lactose utilization. The insert might reduce the expression of β-galactoside permease, delaying import of lactose, resulting in the DLU phenotype. The high probability of DLU should be considered when using lactose-containing media for the isolation of STEC O121.

Identifiants

pubmed: 34809935
pii: S0740-0020(21)00169-6
doi: 10.1016/j.fm.2021.103903
pii:
doi:

Substances chimiques

Escherichia coli Proteins 0
LacY protein, E coli 0
Membrane Transport Proteins 0
Monosaccharide Transport Proteins 0
Symporters 0
beta-Galactosidase EC 3.2.1.23
Glucuronidase EC 3.2.1.31
Lactose J2B2A4N98G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103903

Informations de copyright

Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Auteurs

Alexander Gill (A)

Health Canada, Bureau of Microbial Hazards, 251 Sir Frederick Banting Driveway, Ottawa, Ontario, K1A 0K9, Canada. Electronic address: alex.gill@hc-sc.gc.ca.

Tanis McMahon (T)

Health Canada, Bureau of Microbial Hazards, 251 Sir Frederick Banting Driveway, Ottawa, Ontario, K1A 0K9, Canada.

Forest Dussault (F)

Health Canada, Bureau of Food Surveillance and Science Integration, 251 Sir Frederick Banting Driveway, Ottawa, Ontario, K1A 0K9, Canada.

Karen Jinneman (K)

U.S. Food and Drug Administration, Office of Regulatory Affairs, Office of Regulatory Science, Pacific Northwest Laboratory, 22201 23rd Dr SE, Bothell, WA, 98021, USA.

Rebecca Lindsey (R)

Enteric Diseases Laboratory Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Haley Martin (H)

Enteric Diseases Laboratory Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Devon Stoneburg (D)

Enteric Diseases Laboratory Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Nancy Strockbine (N)

Enteric Diseases Laboratory Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

June Wetherington (J)

U.S. Food and Drug Administration, Office of Regulatory Affairs, Office of Regulatory Science, Pacific Northwest Laboratory, 22201 23rd Dr SE, Bothell, WA, 98021, USA.

Peter Feng (P)

U.S. FDA, Division of Microbiology, College Park, MD, 20740, USA.

Articles similaires

Humans United States Aged Cross-Sectional Studies Medicare Part C
Humans Emergency Service, Hospital Child Child, Preschool Infant
Humans Mobile Applications Hepatitis C Male Female

How Certification Exams Reflect Current Practice.

Tara L Myers, Sean DeGarmo, Marianne Horahan
1.00
Humans Certification Clinical Competence Education, Nursing, Continuing Adult

Classifications MeSH